In recent years, more clinical characteristics have been obtained for dermatomyositis with discoveries of myositis-specific autoantibodies (MSAs) and myositis-associated autoantibodies (MAAs) [12,13]. The gene discussed is MAPKAPK5-AS1; the disease is myositis disease.